Sponsor

Mclean Hospital

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Mclean Hospital appears in 78 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials78
Recruiting shown12
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
One-Day cTBS Over the PrecuneusNCT07758010 · lead sponsor · 2026-09-08
RECRUITING
Synaptic Mechanisms of Continuous Theta Burst Stimulation in DepressionNCT07560878 · lead sponsor · 2026-03-11
RECRUITING
Stress Dynamics and Familial Risk for Depression in Female AdolescentsNCT06816329 · lead sponsor · 2025-10-15
RECRUITING
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological ManipulationNCT05232032 · lead sponsor · 2025-02-01
RECRUITING
Cerebellar Modulation of Cognition in PsychosisNCT06107764 · lead sponsor · 2024-07-31
RECRUITING
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial DysfunctionNCT06191965 · lead sponsor · 2024-06-01
RECRUITING
Ketogenic and Nutritional Interventions for First Episode Bipolar DisorderNCT06221852 · lead sponsor · 2024-03-12
RECRUITING
Enhanced Coordinated Specialty Care for Early PsychosisNCT06071858 · lead sponsor · 2024-02-01
RECRUITING
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide RibosideNCT05245903 · lead sponsor · 2022-05-31
RECRUITING
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major DepressionNCT05630963 · lead sponsor · 2021-12-29
RECRUITING
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in SchizophreniaNCT05343598 · lead sponsor · 2021-10-13
RECRUITING
Neural Correlates of Stress and Perceived Control in Adolescent DepressionNCT04788524 · lead sponsor · 2021-04-23
RECRUITING
Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early PsychosisNCT07503093 · lead sponsor · 2027-01-15
NOT_YET_RECRUITING
Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive DisorderNCT07593222 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101NCT07785102 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Investigating the Protective Impact of LY-2940094 on Stress-induced Depression- and Anxiety-related Phenotypes in HumansNCT06786637 · lead sponsor · 2025-06-01
WITHDRAWN
Open Label Extension Study of NCT06221852NCT06558201 · lead sponsor · 2024-08-28
ENROLLING_BY_INVITATION
SMART Trial to Predict Anhedonia Response to Antidepressant TreatmentNCT05537584 · lead sponsor · 2022-09-30
COMPLETED
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot StudyNCT05380583 · lead sponsor · 2022-05-19
COMPLETED
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's DementiaNCT04430517 · lead sponsor · 2022-03-02
COMPLETED
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)NCT04325529 · lead sponsor · 2021-01-19
ACTIVE_NOT_RECRUITING
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's DementiaNCT04075435 · lead sponsor · 2021-01-11
ACTIVE_NOT_RECRUITING
Implementation of the Care Ecosystem Training Model for Individuals With Dementia in a High-risk, Integrated Care ManagementNCT04556097 · lead sponsor · 2020-12-15
COMPLETED
Families With Substance Use and Psychosis: A Pilot StudyNCT04284813 · lead sponsor · 2020-09-24
COMPLETED
Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant DepressionNCT04239963 · lead sponsor · 2020-08-17
COMPLETED
Biomarkers of Response to Treatment With Frontal Cortex Stimulation for Anxious DepressionNCT03999736 · lead sponsor · 2020-02-13
TERMINATED
Electrophysiological Correlates of Cognition in DepressionNCT03998748 · lead sponsor · 2019-10-08
TERMINATED
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic DisordersNCT03943537 · lead sponsor · 2019-10-01
COMPLETED
Sex, Hormones and Gamma-Aminobutyric Acid (GABA) in Stress Induced Anhedonia in DepressionNCT03031665 · lead sponsor · 2017-10-01
COMPLETED
McLean and Genomind Prospective StudyNCT03113890 · lead sponsor · 2017-09-22
COMPLETED
Neuroimaging Studies of Reward Processing in DepressionNCT03026036 · lead sponsor · 2016-04-01
COMPLETED
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) StudyNCT02642029 · lead sponsor · 2016-02-18
COMPLETED
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserineNCT02304432 · lead sponsor · 2015-09-27
COMPLETED
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI PatientsNCT02188121 · lead sponsor · 2015-02-01
COMPLETED
Brain Mechanisms of Human MotivationNCT01976975 · lead sponsor · 2013-10-01
COMPLETED
An Investigation of Early Life Stress and DepressionNCT01701258 · lead sponsor · 2013-08-01
COMPLETED
Functional Brain Imaging Study of Response to Repetitive TMS (rTMS) Treatment of Major DepressionNCT01768052 · lead sponsor · 2013-06-01
UNKNOWN
Genetic and Neural Predictors of Adolescent DepressionNCT01743716 · lead sponsor · 2013-04-01
COMPLETED
Neurobiology of a Mutation in Glycine Metabolism in Psychotic DisordersNCT01720316 · lead sponsor · 2012-12-10
COMPLETED
Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode PsychosisNCT01688765 · lead sponsor · 2012-10-17
COMPLETED
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain FunctionNCT01598922 · lead sponsor · 2012-10-01
COMPLETED
Neural Components Underlying the Treatment of Adolescent DepressionNCT01717508 · lead sponsor · 2012-10-01
COMPLETED
Functional and Neurochemical Correlates of Treatment Response in Major Depressive DisorderNCT01598324 · lead sponsor · 2012-07-01
TERMINATED
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With SchizophreniaNCT01598896 · lead sponsor · 2012-05-01
TERMINATED
Glutamatergic and GABAergic Mediators of Antidepressant Response in Major DepressionNCT01557946 · lead sponsor · 2012-03-01
COMPLETED
The Effects of Dopamine on Reward ProcessingNCT01253421 · lead sponsor · 2012-02-01
COMPLETED
Depression and Dopamine Transporter Function Study Using C-11 AltropaneNCT01701141 · lead sponsor · 2012-01-01
COMPLETED
Treatment to Enhance Cognition in Bipolar DisorderNCT01470781 · lead sponsor · 2011-06-01
COMPLETED
Dopamine Neurotransmission in Major DepressionNCT01659814 · lead sponsor · 2011-03-01
COMPLETED
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.NCT01148979 · lead sponsor · 2010-09-01
COMPLETED
Acute Glycine Pharmacodynamic StudyNCT01610011 · lead sponsor · 2010-07-01
COMPLETED
Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic StimulationNCT00801567 · lead sponsor · 2010-06-01
WITHDRAWN
Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 TreatmentsNCT01557192 · lead sponsor · 2010-05-01
SUSPENDED
Treatment Resistant Geriatric Depression in Primary CareNCT01392287 · lead sponsor · 2010-05-01
COMPLETED
Low Field Magnetic Stimulation in Mood Disorders Using the LFMS DeviceNCT00578383 · lead sponsor · 2007-11-01
COMPLETED
Effects of Pentazocine Versus Lorazepam on Manic SymptomsNCT00431184 · lead sponsor · 2007-01-01
COMPLETED
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-EffectsNCT00567034 · lead sponsor · 2006-12-01
COMPLETED
An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel SyndromeNCT00401258 · lead sponsor · 2006-11-01
COMPLETED
An Open-Label Trial of Memantine in the Treatment of Binge Eating DisorderNCT00330655 · lead sponsor · 2006-05-01
COMPLETED
AndroGel in Men With Major Depression and Incomplete Response to Antidepressant TreatmentNCT00304746 · lead sponsor · 2006-04-01
COMPLETED

Sponsor roles

lead sponsor63
collaborator15
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.